MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial–mesenchymal transition (MMT) of human peritoneal mesothelial cellsYuki Kimura, Joji Kitayama, Mineyuki Tojo et al.|Scientific Reports|2022Cited by 13
Abstract 3191: The effect of metformin on the tumor immune microenvironmentAkira Saito, Joji Kitayama, Hideyuki Ohzawa et al.|Cancer Research|2021Cited by 0
MiR-29b suppresses peritoneal metastases through inhibition of the mesothelial-mesenchymal transition (MMT) of human peritoneal mesothelial cellsYuki Kimura, Akira Saito, Joji Kitayama et al.|Research Square|2021Cited by 0